MECHANOCHEMICAL APPROACHES TO SELF-REGULATING INSULIN PUMP DESIGN

被引:49
作者
SIEGEL, RA
FIRESTONE, BA
机构
[1] Departments of Pharmacy and Pharmaceutical Chemistry, University of California, San Francisco
基金
美国国家卫生研究院;
关键词
diabetes; insulin pump; pH-sensitive hydrogels; self-regulating insulin delivery system; swelling;
D O I
10.1016/0168-3659(90)90131-C
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Wearable and implantable insulin delivery devices have been proposed by many groups to replace periodic subcutaneous insulin injection. The rationale behind this work lies in the lack of correspondence between insulin and glucose disposition resulting from subcutaneous administration compared with that occurring after pancreatic insulin release. We briefly review features of insulin and glucose disposition processes that impact the design of artificial insulin delivery systems, enabling advantages and disadvantages of currently pursued strategies (electromechanical, biochemical, chemical, mechanochemical) to be identified. We also propose two implantable self-regulating insulin pumps whose action depends on the expansion and contraction of certain pH-sensitive hydrogel membranes that respond to changes in glucose concentration via enzymatic conversion of glucose to gluconic acid. It is shown that the dynamics of pH-sensitive volume changes favor one pump design, based on direct conversion of changes in glucose concentration to mechanical force, over the other, which is an osmotic pump whose semipermeable membrane's permeability to water is sensitive to glucose concentration. © 1990.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 35 条
[1]  
Pfeiffer, Halter, Porte, Insulin secretion in diabetes mellitus, J. Amer. Med. Assoc., 70, pp. 579-588, (1981)
[2]  
O'Connor, Landahl, Grodsky, Role of rate of change of glucose concentration as a signal for insulin release, Endocrinology, 101, pp. 85-88, (1977)
[3]  
Tiran, Avruch, Albisser, A circulation and organs model for insulin dynamics, Amer. J. Physiol: Metab. Gastrointest. Physiol., 6, 4, pp. E331-E339, (1979)
[4]  
Cobelli, Ruggieri, Evaluation of portal/peripheral route and of algorithms for insulin delivery in the closed-loop control of glucose in diabetes — a modeling study, I.E.E.E. Trans. Biomed. Eng., 30, pp. 93-103, (1983)
[5]  
Franetzki, Drug delivery by program or sensor controlled infusion devices, Pharm. Res., 1, pp. 237-244, (1984)
[6]  
Kost, Wolfrum, Langer, Magnetically enhanced insulin release in diabetic rats, J. Biomed. Mater. Res., 21, pp. 1367-1373, (1987)
[7]  
Kost, Langer, Externally modulated insulin delivery systems, Proc. Int. Symp. Controlled Release Bioact. Mater., 15, pp. 162-163, (1988)
[8]  
Liu, Sun, Siddiqui, Chien, Shi, Li, Int. J. Pharm., 44, pp. 197-204, (1988)
[9]  
Sefton, Implantable pumps, CRC Crit. Rev. Biomed. Eng., 14, pp. 201-240, (1986)
[10]  
Fischer, Schenk, Salzsieder, Albrecht, Abel, Freyse, Does physiological blood glucose control require an adaptive control strategy?, I.E.E.E. Trans. Biomed. Eng., 34, pp. 575-582, (1987)